Musar A, McCullagh K, Paul A, et al
Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
this solution contains 100 g of potassium per 1 mL)
The primary ingredient is Poly-L-Lactic Acid (PLLA), which is a biocompatible and biodegradable substance that has been used in medical applications for decades
Understanding the "Master Antioxidant" To understand if NAC is better than glutathione, we must first look at glutathione itself
Review and analysis of FDA approved drugs using lipid-based formulations